| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
(Received for publication, June 18, 1996, and in revised form, September 6, 1996)
From the TAL1/SCL is a basic helix-loop-helix (bHLH)
oncoprotein that is expressed in several cell lines including many
hematolymphoid cells, but not in T- and B-lineage cells. The
TAL1 gene was originally discovered as being
transcriptionally activated by chromosomal rearrangements in T-cell
acute lymphoblastic leukemia (T-ALL). Here we have shown that TAL1 and
the ubiquitously expressed murine bHLH transcription factor ALF1 formed
heterodimers that, compared with ALF1 homodimers, had a more restricted
E-box specificity and bound preferentially to the
glucocorticoid-responsive E-box (Egre) motif
(AA
Volume 271, Number 49,
Issue of December 6, 1996
pp. 31463-31469
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
,
,¶
and
Department of Molecular Biology and the
¶ Department of Medical Microbiology and Immunology, Aarhus
University, C. F. Møllers Allé 130, DK-8000 Aarhus C,
Denmark
GT). Overexpression of the dominant inhibitory HLH
protein Id1 in NIH3T3 cells reduced the transcriptional activity mediated by ALF1 homodimers, whereas the transcriptional activity mediated by TAL1/ALF1 heterodimers was resistant to Id overexpression. Our results show that ALF1 may serve as a dimerization partner for the
bHLH oncoprotein TAL1 and form a complex with a distinctive DNA binding
property. These findings support the hypothesis that the leukemic
characteristics of the TAL1 oncoprotein could be mediated by activation
of a set of target genes as heterodimeric complexes with ubiquitously
expressed bHLH transcription factors such as ALF1 and that a principal
role of TAL1 might be to neutralize an Id-mediated inactivation.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Palomero, D. T. Odom, J. O'Neil, A. A. Ferrando, A. Margolin, D. S. Neuberg, S. S. Winter, R. S. Larson, W. Li, X. S. Liu, et al. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia Blood, August 1, 2006; 108(3): 986 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Huang and S. J. Brandt mSin3A Regulates Murine Erythroleukemia Cell Differentiation through Association with the TAL1 (or SCL) Transcription Factor Mol. Cell. Biol., March 15, 2000; 20(6): 2248 - 2259. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Ethelberg, B. D. Tzschaschel, A. Luz, S. J. Diaz-Cano, F. S. Pedersen, and J. Schmidt Increased Induction of Osteopetrosis, but Unaltered Lymphomagenicity, by Murine Leukemia Virus SL3-3 after Mutation of a Nuclear Factor 1 Site in the Enhancer J. Virol., December 1, 1999; 73(12): 10406 - 10415. [Abstract] [Full Text]
|
|
|
|
|
|
C. G. Begley and A. R. Green The SCL Gene: From Case Report to Critical Hematopoietic Regulator Blood, May 1, 1999; 93(9): 2760 - 2770. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Martiney, L. S. Levy, and J. Lenz Suppressor Mutations within the Core Binding Factor (CBF/AML1) Binding Site of a T-Cell Lymphomagenic Retrovirus J. Virol., March 1, 1999; 73(3): 2143 - 2152. [Abstract] [Full Text]
|
|
|
|
|
|
C. Barat and E. Rassart Members of the GATA Family of Transcription Factors Bind to the U3 Region of Cas-Br-E and Graffi Retroviruses and Transactivate Their Expression J. Virol., July 1, 1998; 72(7): 5579 - 5588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Zaiman, A. Nieves, and J. Lenz CBF, Myb, and Ets Binding Sites Are Important for Activity of the Core I Element of the Murine Retrovirus SL3-3 in T Lymphocytes J. Virol., April 1, 1998; 72(4): 3129 - 3137. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
